This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Chunna Li: Innovator in Pharmaceutical Technology
Introduction
Chunna Li is a prominent inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of aldose reductase inhibitors. His innovative work has the potential to impact the medical industry positively.
Latest Patents
Chunna Li holds a patent for a "Salt of aldose reductase inhibitor, and preparation method and application thereof." This invention presents a salt of an aldose reductase inhibitor, which can be prepared in a crystal form. The salt demonstrates notably improved solubility compared to the original compound, along with lower hygroscopicity, allowing for a more stable existence. This advancement makes it easier to formulate into medicine than the original compound or other salts.
Career Highlights
Chunna Li is associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work at this company has been instrumental in advancing pharmaceutical research and development. He has been recognized for his innovative approaches and dedication to improving drug formulations.
Collaborations
Chunna Li collaborates with talented coworkers, including Zhankun Yang and Hanyu Yang. Their combined expertise contributes to the success of their projects and enhances the research environment at their company.
Conclusion
Chunna Li's contributions to the field of pharmaceutical technology, particularly through his patent on aldose reductase inhibitors, highlight his role as an innovator. His work continues to pave the way for advancements in medicine and drug development.